All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Looking to reach an audience of 1000+ biotech and pharma professionals? Let’s chat. 👍

THE GOOD
Business Development

Ocean Biomedical lands rights to multiple preclinical small molecule assets from Molecure, $600k upfront with biobucks topping out the deal to $32M
Small molecule, cancer, inflammatory disease - Read more

THE GOOD
Clinical Trials

Seraxis’ stem cell-derived replacement islet cells for type 1 diabetes Ph1/2 given FDA go ahead
Cell therapy, type 1 diabetes, stem cell-derived - Read more

MeiraGTx touts positive Ph1/2 data in Parkinson’s disease with their gene therapy AAV-GAD
Gene therapy, Parkinson’s disease, AAV - Read more

Topas Therapeutics alleges positive Ph2a data for TPM502 celiac candidate, though doesn’t yet relieve full details
Epitope-carrying nanoparticles, celiac disease - Read more

Amgen posts positive Ph3 for Uplizna in generalized myasthenia gravis
Monoclonal antibody, generalized myasthenia gravis - Read more

Johnson & Johnson also posts generalized myasthenia gravis data, Ph2/3 trial with nipocalimab in adolescent patients
Monoclonal antibody, generalized myasthenia gravis - Read more

Jazz Pharmaceuticals posts “statistically significant” Ph3 survival data for Zepzelca as part of lung cancer regimen
Small molecule, lung cancer - Read more

Gan & Lee Pharmaceuticals’ GZR18 injectable bests Novo Nordisk’s Ozempic according to Ph2 trial data
GLP-1, obesity, diabetes - Read more

THE GOOD
Company Launches

Tolerance Bio launches with $17.2M, with iPSC-derived therapies to treat immune-mediated diseases
Cell therapy, cancer, autoimmune, induced pluripotent stem cells - Read more

THE GOOD
Earnings & Finances

Johnson & Johnson posts overall strong Q3 earnings driven by Darzalex sales
Monoclonal antibody, multiple myeloma, cancer - Read more

PRESENTED BY YOU?
Get 1000+ sets of biotech/pharma eyeballs on your product or service 👀

Looking to promote your biotech/pharma/life science-focused product or service to a captivated audience of industry professionals?

Consider sponsoring TLDR Biotech - your sponsored feature would go right here!

Want to take the next step (or just learn more)? Just reply to this email or message me on LinkedIn.

⬇️ More Good News ⬇️

THE GOOD
Fundraises

Forbion rakes in over $2.2B for biotech VC investment
Venture capital, biotech investing - Read more

SR One files plans for third fund at $600M
Venture capital, biotech investing - Read more

invIOs €8.2M ($8.9M) Series A
Cell therapy, cancer, tumor infiltrating lymphocyte (TIL) - Read more

Nuclera $75M Series C
Protein manufacturing, manufacturing technology - Read more [Paywall]

Antiverse £3.5M ($4.6M) Seed raise
Antibody, drug discovery, AI, techbio - Read more

MEDiC Life Sciences $5M Strategic funding
Drug discovery, biomarkers, cancer, solid tumor - Read more

Aenitis “strategic” funding, undisclosed amount
Cell & gene therapy manufacturing, acoustofluidic technology - Read more

THE GOOD
Partnerships

Pfizer, TRIANA Biomedicines’ molecular glue degrader drug discovery partnership; up to $1.5B deal
Molecular glue degraders, cancer, drug discovery - Read more

Ripple Therapeutics, Glaukos sign evaluation and licensing agreement for retinal disease drug-delivery tech
Drug delivery, glaucoma, corneal disorders, retinal disease - Read more

THE GOOD
Public Health

WHO lands $1B in pledges for 2025-2028 budget
World health organization, infectious disease, public health - Read more 

ENJOYING THESE NEWSLETTERS?
Support TLDR Biotech🧬🦠🔬 

I’m offering this newsletter for free so it can get out to as many people as possible.

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.*

*Best of all, it’s a work-related news source that you can likely expense. 😉 

THE BAD
Company Shutdown

Notable Labs files for bankruptcy, fails to bring in-licensed Boehringer Ingelheim asset volasertib to market
Small molecule, acute myeloid leukemia, cancer - Read more

THE BAD
Lawsuits

GSK sues Moderna for alleged patent infringement related to COVID-19 mRNA vaccine tech
mRNA vaccine, COVID-19 - Read more

THE BAD
Layoffs

Walgreens to shutter 1200 stores as part of new CEO’s turnaround attempt
Consumer health, pharmacy - Read more

THE BAD
Strategic Plans

Johnson & Johnson makes multiple pipeline cuts, including Alzheimer’s hopeful seltorexant
Small molecule, Alzheimer’s disease, pipeline reprioritization - Read more

THE UGLY
Lawsuits

Sackler family (Purdue Pharma) calls allegations of funnelling billions into offshore accounts to shield from opioid lawsuits “utterly meritless”
Opioid settlements - Read more [Paywall]

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here